[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"peutz-jeghers-syndrome-pjs\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:peutz-jeghers-syndrome-pjs":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":56},"100209193","phase-3-the-cancer-of-the-pancreas-screening-5-caps5study-100209193",false,"NCT02000089","The Cancer of the Pancreas Screening-5 CAPS5)Study","CAPS5","Inclusion Criteria:\n\n* Hereditary Pancreatitis or\n* Peutz-Jeghers Syndrome or\n* Strong family history of pancreas cancer on one side of the family tree or\n* Confirmed germline mutation carrier (BRCA2, FAMMM (CDKN2A\u002Fp16), PALB2, BRCA1, ATM, HNPCC, Lynch Syndrome (hMLH1, hMSH2, PMS2, hMSH6, EpCAM) PRSS1, PRSS2, R122H, N291l, SPINK1, CFTR\n* Endoscopic evaluation of pancreas scheduled\n\nExclusion Criteria:\n\n* Medical comorbidities or coagulopathy that contraindicate endoscopy\n* Prior surgery that prevent optimal endoscopic ultrasound such as partial or complete gastrectomy with Bilroth or Roux-en-Y anastomosis\n* Stricture or obstruction in the upper GI tract that does not allow passage of the echoendoscope\n* Poor performance status\n* Inability to provide informed consent\n* Pregnancy.","ALL","18 Years",{"count":19,"type":20},9000,"ESTIMATED","INTERVENTIONAL",[23],"PHASE3","Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.",[26,27,28,29,30],"Pancreas Cancer","Peutz-Jeghers Syndrome (PJS)","Gene Mutation","Germline Mutation Carrier","Lynch Syndrome",[32,33,34,35,36,37,38,39,30,40,41,42,43],"familial pancreas cancer","(Peutz-Jeghers Syndrome) PJS","Breast cancer (BRCA) 2","Partner and Locator of BRCA2 (PALB2)","Familial Atypical Multiple Mole- Melanoma (FAMMM)","p16, CDKN2A","Breast Cancer (BRCA)1","(hereditary non-polyposis colorectal cancer or Lynch syndrome) HNPCC","hereditary pancreatitis","Protease Serine (PRSS)","Chymotrypsin C (CTRC)","Ataxia Telangiectasia Mutated(ATM)","RECRUITING","2025-10-08",{"date":47,"type":48},"2025-10-09","ACTUAL",{"date":50,"type":48},"2014-01-06",{"date":52,"type":20},"2029-06",{"name":54,"class":55},"Johns Hopkins University","OTHER",9]